Researchers call for increased screening for parasitic disease linked to HIV and cervical cancer risk

by Liverpool School of Tropical Medicine

edited by Gaby Clark, reviewed by Robert Egan

Gaby Clark

Scientific Editor

Meet our editorial team
Behind our editorial process

Robert Egan

Senior Editor

Meet our editorial team
Behind our editorial process Editors' notes

This article has been reviewed according to Science X's editorial process and policies. Editors have highlighted the following attributes while ensuring the content's credibility:

fact-checked

peer-reviewed publication

trusted source

proofread

The GIST Add as preferred source

New research from Liverpool School of Tropical Medicine (LSTM) has highlighted the need to test millions of women and girls for female genital schistosomiasis (FGS), a neglected disease that can increase the risk of chronic illness, HIV and cervical cancer.

In a new paper published in The Lancet Microbe, researchers from LSTM, the Malawi-Liverpool-Wellcome Programme (MLW) and the London School of Hygiene & Tropical Medicine (LSHTM) are calling for FGS to be urgently integrated into sexual and reproductive health services to improve diagnosis and treatment.

FGS is caused by infection with the parasitic worm Schistosoma haematobium, transmitted through contact with infested freshwater. Parasite eggs become trapped in reproductive tissues, causing inflammation, lesions and scarring. The disease affects at least 40 million women globally, primarily in sub-Saharan Africa, yet remains largely absent from reproductive health care services.

The study examined how FGS interacts with other gynecological infections and found evidence that chronic inflammation and tissue damage caused by the disease may increase vulnerability to infections including HIV and human papillomavirus (HPV), the leading cause of cervical cancer.

The researchers argue that integrating FGS screening into existing HIV, cervical cancer and sexual health programs could improve diagnosis and care for millions of women. Proposed approaches include combined HPV and FGS testing from a single genital sample, improved health care worker training, and the use of new molecular and AI-supported diagnostic tools.

Professor Amaya Bustinduy, professor of global pediatric and adolescent infectious diseases at LSHTM and senior author on the paper, said, "Female genital schistosomiasis remains one of the most neglected gynecological conditions affecting women and girls in Africa. Despite the scale of the problem, it is still routinely overlooked within both neglected tropical disease programs and wider sexual and reproductive health care services."

Professor Russell Stothard, professor of medical parasitology at LSTM and co-author of the paper, said, "This paper highlights the urgent need to move beyond isolated disease-specific approaches and toward integrated care that recognizes the overlap between FGS, HIV, HPV and other reproductive health conditions."

The paper draws on findings from the Hybridisation in Urogenital Schistosomiasis (HUGS) study in Malawi, which identified high levels of co-infection between FGS and other genital infections.

The study also highlights the emerging role of zoonotic and hybrid schistosome species, including parasites usually associated with livestock, which have now been detected in genital samples from women with FGS. Researchers say these findings raise important questions about diagnosis, treatment effectiveness and disease control.

Stothard added, "The emergence of zoonotic and hybrid schistosome species also reinforces the importance of One Health approaches that consider human, animal and environmental health together."

The authors warn that fragmented, disease-specific programs are failing women living in endemic areas and say continued neglect of FGS risks undermining wider global health goals.

Publication details

Olimpia Lamberti et al, Female genital schistosomiasis, including zoonotic and hybrid schistosomes, and other cervicovaginal co-infections, The Lancet Microbe (2026). DOI: 10.1016/j.lanmic.2026.101425

Journal information: The Lancet Microbe

Key medical concepts

Schistosoma haematobiumHPV InfectionsCervical Cancer

Clinical categories

Obstetrics & gynecologyInfectious diseasesReproductive healthCommon illnesses & PreventionWomen's healthHIV & AIDS Provided by Liverpool School of Tropical Medicine Who's behind this story?

Gaby Clark

MA in English, copy editor since 2021 with experience in higher education and health content. Dedicated to trustworthy science news. Full profile →

Robert Egan

Bachelor's in mathematical biology, Master's in creative writing. Well-traveled with unique perspectives on science and language. Full profile →

Citation: Researchers call for increased screening for parasitic disease linked to HIV and cervical cancer risk (2026, July 2) retrieved 2 July 2026 from https://medicalxpress.com/news/2026-07-screening-parasitic-disease-linked-hiv.html This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.